Exclusive: Gene editing pioneer Feng Zhang launches new startup in Cambridge

Soon-to-be-launched Beam Therapeutics joins a crowded field of companies — many of them based in Kendall Square — that are seeking to cure diseases by altering human DNA.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.